0000950123-23-007806.txt : 20230814 0000950123-23-007806.hdr.sgml : 20230814 20230814111923 ACCESSION NUMBER: 0000950123-23-007806 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioImpact Capital LLC CENTRAL INDEX KEY: 0001687078 IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 231167466 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: MPM Oncology Impact Management LP DATE OF NAME CHANGE: 20161007 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001687078 XXXXXXXX 06-30-2023 06-30-2023 false BIOIMPACT CAPITAL LLC

399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116

13F HOLDINGS REPORT 028-20107 000309865 801-119133 N Brendan Furey (617) 425-9222 /s/Brendan Furey Boston MA 08-11-2023 0 34 496602631 false INFORMATION TABLE 2 25671.xml INFORMATION TABLE FOR FORM 13F Adaptimmune Therapeutics plc Common 00653A107 4713719 5095912 SH SOLE 5095912 0 0 Amicus Therapeutics Inc. Common 03152W109 6482706 516139 SH SOLE 516139 0 0 Avadel Pharmaceuticals PLC Sponsored ADR 05337M104 6344635 384990 SH SOLE 384990 0 0 Axsome Therapeutics, Inc. Common 05464T104 6725090 93586 SH SOLE 93586 0 0 Chinook Therapeutics, Inc. Common 16961L106 38550859 1003406 SH SOLE 1003406 0 0 Crinetics Pharmaceuticals Inc. Common 22663K107 8632535 479053 SH SOLE 479053 0 0 Cullinan Oncology, Inc. Common 230031106 82295364 7648268 SH SOLE 7648268 0 0 Edgewise Therapeutics Inc Common 28036F105 5524185 712798 SH SOLE 712798 0 0 Geron Corporation Common 374163103 29504041 9191290 SH SOLE 9191290 0 0 Harpoon Therapeutics, Inc. Common 41358P106 2269662 3196707 SH SOLE 3196707 0 0 Inozyme Pharma Inc. Common 45790W108 1820950 326921 SH SOLE 326921 0 0 Insmed Incorporated Common 457669307 11177577 529743 SH SOLE 529743 0 0 Kalvista Pharmaceuticals Inc Common 483497103 6853842 761538 SH SOLE 761538 0 0 Karuna Therapeutics Inc Common 48576A100 11579573 53399 SH SOLE 53399 0 0 Intellia Therapeutics, Inc. Common 45826J105 22210378 544639 SH SOLE 544639 0 0 Iovance Biotherapeutics Inc Common 462260100 20768831 2950118 SH SOLE 2950118 0 0 iTeos Therapeutics, Inc. Common 46565G104 23116285 1745943 SH SOLE 1745943 0 0 Iveric Bio Inc Common 46583P102 47784803 1214662 SH SOLE 1214662 0 0 Madrigal Pharmaceuticals inc Common 558868105 8780541 38011 SH SOLE 38011 0 0 Moonlake Immunotherapeutics Common 61559X104 15050661 295111 SH SOLE 295111 0 0 Olema Pharmaceuticals, Inc. Common 68062P106 4176375 462500 SH SOLE 462500 0 0 Oncorus, Inc. Common 68236R103 96270 2377031 SH SOLE 2377031 0 0 Phathom Pharmaceuticals inc Common 71722W107 4042994 282332 SH SOLE 282332 0 0 Reata Pharmaceuticals, Inc. Common 75615P103 23907377 234478 SH SOLE 234478 0 0 REGENXBIO Inc. Common 75901B107 13127793 656718 SH SOLE 656718 0 0 Relay Therapeutics Inc. Common 75943R102 17010862 1354368 SH SOLE 1354368 0 0 Repare Therapeutics, Inc. Common 760273102 17349602 1639849 SH SOLE 1639849 0 0 Revolution Medicines, Inc. Common 76155X100 7313664 273408 SH SOLE 273408 0 0 Travere Therapeutics Inc. Common 89422G107 8491715 552846 SH SOLE 552846 0 0 Ventyx Biosciences Inc Common 92332V107 1041302 31747 SH SOLE 31747 0 0 Verve Therapeutics, Inc Common 92539P101 16086375 857940 SH SOLE 857940 0 0 Viridian Therapeutics Inc Common 92790C104 6074134 255323 SH SOLE 255323 0 0 Xeris Biopharma Holdings Inc Common 98422E103 10414497 3974999 SH SOLE 3974999 0 0 Werewolf Therapeutics, Inc. Common 95075A107 7283434 2388011 SH SOLE 2388011 0 0